MC Plus Material – 04_Overview of the FY2026 Medical Fee Revision: 4. Comprehensive and Chronic Inpatient Care, Page 17 – Center for Health Policy Information

News Highlights

This document from the Center for Health Policy Information outlines the FY2026 medical fee revision, focusing on comprehensive and chronic inpatient care. Key points for M&A and business succession include mid-to-long-term management and succession strategies considering the revision cycle, economies of scale through group participation (maintaining facility standards and distributing equipment investment burdens), and utilizing tax incentives by transitioning to specific or social medical corporations.

Perspective from the M&A Medical Editorial Department

This material, focusing on the FY2026 medical fee revision and specifically on comprehensive and chronic inpatient care, offers more than just advance information on fee adjustments for healthcare providers. From the perspective of a medical M&A intermediary, it highlights the renewed necessity for mid-to-long-term management and succession strategies that consider the revision cycle. Particularly, chronic and comprehensive care are sectors highly susceptible to medical fee revisions. In cases where maintaining facility standards, distributing the burden of equipment investment, and utilizing tax schemes such as transitioning to specific or social medical corporations are considered, standalone survival may become increasingly challenging. Economies of scale through group affiliation can be an effective means to overcome these challenges, and for healthcare institutions facing a lack of successor, it can be an option to simultaneously achieve business succession and strengthen the management base.

Points Raised by This News

• Understanding the trends in comprehensive and chronic inpatient care for the FY2026 revision is fundamental to management strategy.
• Economies of scale through group participation directly contribute to maintaining facility standards and distributing equipment investment burdens.
• Considering tax schemes with a view to transitioning to specific or social medical corporations is important for succession financial strategy.
• Developing mid-to-long-term management and succession plans with the revision cycle in mind is an urgent issue.

Practical Questions Arising from This News

• How is our institution’s chronic care ward’s billing criteria expected to be affected by this revision?
• Specifically, what kind of facility standards can be maintained and equipment investment burdens distributed by joining a group?
• Are there benefits for our institution in its current state to transition to a specific or social medical corporation? Is coordination with a tax accountant necessary?

If You Feel “Should I Consult Too?”

For those concerned about the trends in comprehensive and chronic inpatient care, particularly regarding the FY2026 medical fee revision, this is a good opportunity to review your institution’s management and succession strategies. Especially if you are considering future equipment investments and the utilization of tax schemes while minimizing the impact of the revision, consulting with experts early on may reveal more advantageous options. If you are unsure whether your institution can handle this alone, we recommend consulting with an M&A brokerage firm.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, operating on a full success fee basis. Consultations are handled with strict confidentiality. Free consultation here